Torres Jada Benn, Kittles Rick A
Section of Genetic Medicine, Department of Medicine, The University of Chicago, 5841 South Maryland Avenue, MC6091, Chicago, IL 60637, USA.
Curr Hypertens Rep. 2007 Jun;9(3):196-201. doi: 10.1007/s11906-007-0035-1.
The post-human genome sequencing era has presented several daunting challenges for biomedical research. How do we begin to quantify the level of sequence variation that exists within and between human populations? This challenge has serious implications for the enigma called "race," genetic ancestry, group definition, and membership. Another challenge has been the attempt to understand the role DNA sequence variation contributes to variation in susceptibility to common complex diseases. How these challenges are met will have an impact on our ability to determine if health disparities (eg, cardiovascular disease) are due to biological differences. Here we discuss genetic variation among African Americans and Hispanic Americans and its implications for "race." We believe that the casual use of "race" to define groups in biomedical research has contributed to our limited understanding of complex disease etiology and risk factors driving health disparities.
后人类基因组测序时代给生物医学研究带来了诸多艰巨挑战。我们如何开始量化人类群体内部和群体之间存在的序列变异水平?这一挑战对所谓的“种族”、遗传血统、群体定义和成员身份等谜团有着严重影响。另一个挑战是试图理解DNA序列变异在常见复杂疾病易感性变异中所起的作用。如何应对这些挑战将影响我们判断健康差异(如心血管疾病)是否由生物学差异所致的能力。在此,我们讨论非裔美国人和西班牙裔美国人之间的遗传变异及其对“种族”的影响。我们认为,在生物医学研究中随意使用“种族”来定义群体,导致我们对驱动健康差异的复杂疾病病因和风险因素的理解有限。